Renal hemorrhage caused by acquired inhibitors to coagulation factors VIII and V in a hemodialysis patient.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 28508982)

Published in CEN Case Rep on July 25, 2016

Authors

Naoya Niwa¹^,2, Tadashi Yoshida³^,4, Ryuichi Mizuno², Mototsugu Oya², Matsuhiko Hayashi¹^,5

Author Affiliations

1: Apheresis and Dialysis Center, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
2: Department of Urology, School of Medicine, Keio University, Tokyo, Japan.
3: Apheresis and Dialysis Center, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. tayoshida-npr@umin.ac.jp.
4: Department of General Medicine, School of Medicine, Keio University, Tokyo, Japan. tayoshida-npr@umin.ac.jp.
5: Department of General Medicine, School of Medicine, Keio University, Tokyo, Japan.

Articles cited by this ↗

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood (2006) 3.71

Acquired factor V inhibitor. A problem-based systematic review. Thromb Haemost (2009) 1.56

Management of acquired haemophilia A. J Thromb Haemost (2011) 1.34

The molecular basis of factor V and VIII procofactor activation. J Thromb Haemost (2009) 1.01

Acquired haemophilia: an overview for clinical practice. Eur J Haematol (2015) 0.96

A case of factor VIII inhibitor-positive acquired hemophilia treated by plasmapheresis. Ther Apher (1999) 0.86

Articles by these authors ⇆

Posterior reversible encephalopathy syndrome in a uremic patient with autosomal recessive polycystic kidney disease. CEN Case Rep (2015) 0.75

Idiopathic hematocele in a patient receiving peritoneal dialysis. Clin Exp Nephrol (2016) 0.75